SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?

Rapid antidepressant effects associated with ketamine have shifted the landscape for the

Ketamine and Other NMDA Antagonists: Early Clinical Trials and

NMDA receptor trafficking in synaptic plasticity and

NMDA receptor trafficking in synaptic plasticity and

NMDA receptor subunit diversity: impact on receptor properties

SciELO - Brazil - Does mismatch negativity have utility for NMDA

SciELO - Brazil - Does mismatch negativity have utility for NMDA

PDF) Cannabinoids and Vanilloids in Schizophrenia

Depolarizing GABAA current in the prefrontal cortex is linked with

PDF) Neuroprogression in schizophrenia: Pathways underpinning

PDF) Does mismatch negativity have utility for NMDA receptor drug

PDF) Does mismatch negativity have utility for NMDA receptor drug